Ohio diabetes patient files Actos bladder cancer lawsuit against Takeda

by Jim Orr

An Ohio man has filed a pharmaceutical liability lawsuit against Takeda Pharmaceuticals alleging that he was diagnosed with bladder cancer after being treated with the diabetes drug Actos. Plaintiff William Harstein and his wife, Phyllis, filed the lawsuit in the U.S. District Court for the Western District of Louisiana in July 2015, just weeks after he was diagnosed with bladder cancer.

According to the lawsuit against Takeda, William Harstein began taking Actos in November 2006 to treat his type II diabetes symptoms. In May 2015, Harstein was diagnosed with bladder cancer.

Numerous studies have confirmed the link between Actos and bladder cancer. In 2005, a three year study revealed that men who used Actos were more likely to develop bladder cancer. After a second three year study confirmed the link between Actos and cancer of the bladder, the FDA launched an investigation into the side effect risks of the diabetes drug. After the American Diabetes Association published a study which confirmed the Actos-bladder cancer link, health officials in France and Germany withdrew the drug from sales in those countries.

But despite numerous studies linking the diabetes drug to an increased bladder cancer risk and the French and German Actos recalls, Takeda Pharmaceuticals continued to promote the drug for sale in the U.S. Numerous product liability lawsuits have been filed against Takeda for the company’s alleged negligence in continuing to market Actos despite numerous warnings about the dangers of this medication.

William Harstein’s Actos lawsuit against Takeda seeks compensation for medical expenses, pain and suffering, mental anguish, and expenses related to costs of living increases result from the diagnosis. Phyllis Harstein is also asking the court to award compensation for loss of consortium from her husband as he is treated for his illness.

Actos Lawsuits Filed Against Takeda

Patients who were diagnosed with bladder cancer after taking Actos may be eligible to file a lawsuit and receive compensation for their injuries and medical costs. Actos users who have been diagnosed with pancreatic cancer or prostate cancer may also qualify to file a lawsuit.

Because the risk of bladder cancer, prostate cancer, and pancreatic cancer increases the longer a patient has been treated with Actos—and because it may take years after a patient has been treated with the diabetes drug before the first symptoms of cancer are detectable—patients who were treated with Actos years ago may only now develop signs of cancer. Actos users who have been diagnosed with bladder, pancreatic, or prostate cancer—or those who developed symptoms of these diseases—may be eligible to file a lawsuit and pursue compensation for their injuries. The first step in taking action to file a case is to speak with an experienced team of attorneys to help guide you through the process of filing a lawsuit.

Our law firm, Heygood, Orr & Pearson, is pursuing Actos lawsuits on behalf of our clients and will be involved closely with the Actos MDL and other litigation matters regarding the diabetes drug. Our attorneys have accumulated years of training and experience in handling product liability lawsuits involving dangerous drugs or defective medical devices, including cases involving the fentanyl pain patch, Yaz, and Avandia. The lawyers at Heygood, Orr & Pearson have achieved verdicts and settlements of more than $200 million on behalf of our clients in lawsuits relating to dangerous pharmaceuticals, medical devices, and other medical products. Our attorneys will work diligently on your behalf to ensure that you receive the results that you deserve in your case.

For a free legal consultation from an attorney about filing a lawsuit and to learn more about whether you may qualify to file a case, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001. You can also contact us 24 hours a day by following the link to our free case evaluation form and answering a few simple questions about your history to get started.